Overview
Pseudotuberculosis, caused by Yersinia pseudotuberculosis, can present with symptoms resembling Kawasaki disease, particularly in endemic regions, complicating early diagnosis 1.Diagnosis
Clinical suspicion based on endemic region and symptomatology (fever, rash, abdominal symptoms) 1.
Serological testing for anti-Y. pseudotuberculosis antibodies can confirm diagnosis despite negative cultures due to prior antimicrobial use 1.
Culture of stool or other relevant samples, though often negative if antibiotics were used previously 12.Management
First-line treatment: Ampicillin (specific dose not detailed in abstracts) 2.
Adjunctive measures: Supportive care including management of fever, rash, and abdominal symptoms 2.Special Populations
Pediatrics: Ampicillin therapy does not significantly shorten clinical symptoms but reduces fecal excretion of the organism 2.
Comorbidities: No specific guidance provided in the abstracts regarding comorbidities 12.Key Recommendations
Utilize serological testing for anti-Y. pseudotuberculosis antibodies in suspected cases, especially when clinical suspicion is high despite negative cultures 1 (Evidence: Moderate).
Consider ampicillin therapy in pediatric patients with confirmed or highly suspected Y. pseudotuberculosis infection to reduce fecal excretion of the organism, though it may not alter clinical symptom duration 2 (Evidence: Moderate).
Maintain high clinical suspicion for pseudotuberculosis in endemic areas, particularly when symptoms overlap with Kawasaki disease, to avoid diagnostic delays 1 (Evidence: Expert opinion).References
1 Suzuki S, Suzuki K, Furukawa T, Nakajima M, Sakai H. Past Endemic Izumi Fever or Yersinia pseudotuberculosis Infection Reappears Sporadically. Internal medicine (Tokyo, Japan) 2024. link
2 Sato K, Ouchi K, Komazawa M. Ampicillin vs. placebo for Yersinia pseudotuberculosis infection in children. The Pediatric infectious disease journal 1988. link